-
Product Insights
Retinopathy - Drugs In Development, 2024
Empower your strategies with our Retinopathy – Drugs In Development, 2024 report and make more profitable business decisions. Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of a systemic disease such as diabetes or hypertension. The Retinopathy...
-
Product Insights
Retinal Vascular Occlusion - Drugs In Development, 2024
Empower your strategies with our Retinal Vascular Occlusion – Drugs In Development, 2024 report and make more profitable business decisions. Retinal vascular occlusion is a condition that affects the blood vessels in the retina, the light-sensitive layer of tissue at the back of the eye. It occurs when a blood vessel is blocked by a clot or compressed by another vessel, preventing blood from reaching or leaving the retina. This can cause vision loss or blindness in the affected eye. There...
-
Product Insights
Retinal Vein Occlusion - Drugs In Development, 2024
Empower your strategies with our Retinal Vein Occlusion – Drugs In Development, 2024 report and make more profitable business decisions. Retinal vein occlusion is a blockage in one of the veins returning blood flow from the retina. The retina is where images are converted to nerve signals. The primary symptom of retinal vein occlusion is a sudden painless change in vision. Predisposing factors are atherosclerosis, macular edema, diabetes, high blood pressure, high cholesterol, and age. The Retinal Vein Occlusion drugs in...
-
Product Insights
Choroidal Neovascularization - Drugs In Development, 2024
Empower your strategies with our Choroidal Neovascularization – Drugs In Development, 2024 report and make more profitable business decisions. Choroidal neovascularization (CNV) involves the growth of new blood vessels that originate from the choroid, the pigmented vascular layer of tissue behind the retina. Symptoms include painless loss of vision, metamorphopsia, and color disturbances. Treatment includes anti-vascular endothelial growth factor (anti-VEGF) agents, laser photocoagulation, and photodynamic therapy. The Choroidal Neovascularization drugs in development market research report provide comprehensive information on the therapeutics...
-
Product Insights
Juvenile Macular Degeneration (Stargardt Disease) - Drugs In Development, 2024
Empower your strategies with our Juvenile Macular Degeneration (Stargardt Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults. The most common form of juvenile macular degeneration is Stargardt disease, an inherited autosomal recessive syndrome. Signs and symptoms include blurry or fuzzy vision; dark, empty spots in the center of vision; and difficulty reading or performing detail work. Risk factors include arteriosclerosis,...
-
Product Insights
Macular Edema - Drugs In Development, 2024
Empower your strategies with our Macular Edema – Drugs In Development, 2024 report and make more profitable business decisions. Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged blood vessels in the retina begin to leak fluids, including small amounts of blood, into the...
-
Product Insights
Myopia - Drugs In Development, 2024
Empower your strategies with our Myopia – Drugs In Development, 2024 report and make more profitable business decisions. Myopia, a form of nearsightedness, is a ophthalmological disorder that results in blurred vision when looking at distant objects. This occurs due to the improper refraction of light in the eye, causing the focal point to fall in front of the retina, rather than on it. Close-up objects can still be seen clearly. The underlying cause of myopia can be attributed to specific...
-
Product Insights
Allergic Conjunctivitis - Drugs In Development, 2024
Empower your strategies with our Allergic Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic conjunctivitis occurs when the clear layer of tissue lining the eyelids and covering the white of the eye (conjunctiva) becomes swollen or inflamed due to a reaction to pollen, dander, mold, or other allergy-causing substances. Symptoms include intense itching, puffy eyelids, widened (dilated) vessels in the clear tissue covering the white of the eye, and stringy eye discharge. Treatment includes antihistamine...
-
Product Insights
Presbyopia - Drugs In Development, 2024
Empower your strategies with our Presbyopia – Drugs In Development, 2024 report and make more profitable business decisions. Presbyopia is an eye condition in which the eyes slowly lose the ability to focus quickly on objects that are close. Presbyopia happens in people as they age. Signs and symptoms include headaches, eye strain, difficulty reading small print, and fatigue. Risk factors include anemia, diabetes, cardiovascular disease, hyperopia, multiple sclerosis, myasthenia gravis, and eye trauma. The Presbyopia drugs in development market research...
-
Product Insights
Graves' Ophthalmopathy - Drugs In Development, 2024
Empower your strategies with our Graves' Ophthalmopathy – Drugs In Development, 2024 report and make more profitable business decisions. Graves’ ophthalmopathy is an autoimmune condition where the thyroid gland mistakenly senses harmful cells and releases antibodies to combat them. Since there are no harmful cells, the released antibodies end up fusing with muscles in the eyes, causing the onset of Graves' ophthalmopathy. Symptoms include eye redness, eye inflammation, eyelid retraction, and eye weakness. Treatment includes radioiodine therapy, anti-thyroid medications, and thyroid...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.